Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yanchuang Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
The average size of a deal this fund participated in
Portfolio companies 12
Rounds per year 1.17
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yanchuang Capital:
Typical Co-investors
Yanchuang Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yanchuang Capital:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3Rodeo California, Los Angeles, United States
Agri Vie Cape Town, South Africa, Western Cape
AmWINS Group Charlotte, North Carolina, United States
Biolink Capital Bagsværd, Denmark, Hovedstaden
Dentsu Ventures Chiyoda, Japan
Far East Ventures Central, Central Region, Singapore
Jiang Wei Guquan Touzi (Shanghai) Co., Ltd. China, Shanghai
Lauxera Capital Partners France, Ile-de-France, Paris
Manatt Ventures New York, New York, United States
OZ Verlag -
PACCAR Bellevue, United States, Washington
Patria Mobile -
SonicWALL California, Santa Clara, United States
SWL Healthcare Ventures -
Syrus Partners Seattle, United States, Washington
Three Cairns Group New York, New York, United States
Zuiyou Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Laekna Therapeutics

$61M18 May 2022 Shanghai, China

TenNor Therapeutics

$40M30 Mar 2022 New Jersey, United States

Innoforce Pharmaceuticals

Health Care
$57M06 Dec 2021 Hangzhou, Zhejiang, China

Compson Agricultural Technology

Life Science
$15M12 Aug 2021 Beijing, Beijing, China


Medical Device
21 Apr 2021 Gusu District, Jiangsu, China

Health Care
$120M22 Mar 2021 Shanghai, China

Lingdi Technology

3D Technology
$30M11 Mar 2021 -

Asieris Pharmaceuticals

Health Care
$44M28 Jun 2020 Shanghai, China

Asieris Pharmaceuticals

Health Care
$15M24 Mar 2020 Shanghai, China


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yanchuang Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: